What You Should Know:
- AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal ECG system, the AI-powered KardiaMobile® 6L Max.
- Accompanying this device is KardiaAlert™, a first-of-its-kind feature available exclusively to subscribers of AliveCor's KardiaCare service. Together, these innovations aim to provide users with more comprehensive detections and insights, monitor heart rhythms for
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Heart Failure’s Hidden Price: Understanding the True Cost of Cardiac Events and AI’s Role in Reducing Expenses
Cardiovascular disease (CVD) is a leading cause of death and a growing financial strain on the U.S. healthcare system, costing an estimated $252.2 billion annually. With one in every eight healthcare dollars spent on cardiac care, the urgency to control costs while improving patient outcomes has never been greater.
As traditional care models struggle to keep up with demand, we are faced with an important question: How can we make cardiac care more sustainable, ensuring the healthcare
Read More
HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players
What You Should Know:
- HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry.
- GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.
Understanding the Unique Cardiovascular Risks of Retired NFL
Read More
Mayo Clinic, SandboxAQ Expand Collaboration to Advance AI Cardiac Diagnostics in Amyloidosis
What You Should Know:
- Mayo Clinic is expanding its collaboration with SandboxAQ, a provider of artificial intelligence (AI) medical apps to explore the use of electrocardiography (ECG) and magnetocardiography (MCG) technologies for characterizing disease progression and treatment response in patients with amyloidosis.
- The expanded partnership highlights the potential of combining AI and advanced sensing technology to revolutionize cardiac diagnostics.
Improved Detection and
Read More
FIRE1 Secures $120M for Heart Failure Management Platform
What You Should Know:
- FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise
Read More
Abbott Launches Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring
What You Should Know:
- Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF, designed to improve outcomes for patients with worsening heart failure.
- The first-of-its-kind trial will leverage AI and Abbott's CardioMEMS™ HF System to identify patients who may benefit from earlier intervention with advanced therapies, such as a HeartMate 3™ left ventricular assist device (LVAD).
Addressing the Challenges of Advanced Heart Failure
Heart
Read More
Medicare Approves Cleerly’s AI-Powered Heart Scan for Millions of Beneficiaries
What You Should Know:
- In a significant step towards improving cardiovascular care, several Medicare Administrative Contractors (MACs) have granted coverage for Cleerly's AI-enabled Quantitative Coronary Topography (AI-QCT) scans.
- The decision expands access to Cleerly's potentially life-saving technology for Medicare beneficiaries at risk of heart attacks.
Expanding Access to Innovative Cardiac Care
Cleerly, a company dedicated to eradicating heart attacks, sought MAC
Read More
Amwell Integrates with Hello Heart to Offer Digital Cardiovascular Solution
What You Should Know:
- Amwell, a digital health platform, has joined forces with Hello Heart, a pioneer in preventive heart health, to offer a comprehensive digital solution for individuals at risk of cardiovascular disease.
The partnership integrates Hello Heart's innovative program into Amwell's Converge platform, providing a seamless and accessible way for health plan members to manage their heart health.
Addressing a Critical Need
Heart disease remains the leading
Read More
WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device
What You Should Know:
- WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.
- The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.
Tackling the
Read More
Cedars Sinai Researchers Uses AI to Analyze Regular Chest CT Scans to Predict Heart Disease Risk
What You Should Know:
- Researchers at Cedars-Sinai have developed a new method using artificial intelligence (AI) to assess cardiovascular disease risk during a routine chest computed tomography (CT) scan without contrast dye.
- The recent study published in Nature Communications, could significantly reduce the cost and invasiveness of identifying patients at risk for heart disease.
Leveraging Existing Data for Better Risk Assessment
Traditionally, CT scans with contrast
Read More
